Dopamine–prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity
Crossref DOI link: https://doi.org/10.1038/tp.2016.50
Published Online: 2016-04-19
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gragnoli, C
Reeves, G M
Reazer, J
Postolache, T T
Text and Data Mining valid from 2016-04-19
Version of Record valid from 2016-04-19
Article History
Received: 31 July 2015
Revised: 15 February 2016
Accepted: 19 February 2016
First Online: 19 April 2016
Competing interests
: The authors declare no conflict of interest.